Clinical Adventurer
When seconds count, your patient’s lab results can be the difference between catching a heart attack early or missing a silent killer. In this episode, we break down cardiac biomarkers — what they really mean, how to interpret them, and why troponins reign supreme in today’s high-stakes cardiac care. We’ll walk you through the science, the pitfalls, and the nursing implications so you can make sense of those critical labs in real time. 🧠 Key Topics Covered: * What Are Cardiac Biomarkers? * Substances released during cardiac muscle injury * Their role in diagnosing Acute Myocardial Infarction (AMI) and Acute Coronary Syndromes (ACS) * Troponin I and T – The Gold Standard: * Why they replaced AST, LDH, and CK-MB * Sensitivity, specificity, and timing of elevation * Clinical relevance of high-sensitivity troponin assays * Other Biomarkers in Context: * CK-MB and myoglobin: When they’re still used * BNP and NT-proBNP: For heart failure assessment (vs ischemia) * Timing and Trends Matter: * Serial troponin testing and rise/fall patterns * How early peaks and delayed elevations affect diagnosis * False Positives and Interfering Factors: * Sepsis, renal failure, pulmonary embolism, and chronic disease * Pre-analytical issues: Hemolysis, improper timing, and specimen handling * Diagnostic Criteria for AMI (Fourth Universal Definition): * Troponin changes + clinical signs + ECG changes * Type 1 vs Type 2 MI differentiation * Nursing and Interprofessional Implications: * When to alert the provider * How to prepare patients for serial testing * Collaborating with lab, cardiology, and emergency teams for timely action
40 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de Clinical Adventurer community!